
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Analysis of the molecular mechanism of SARS-CoV-2 antibodies
Dongfu Jin, Jing Wei, Jian Sun
Biochemical and Biophysical Research Communications (2021) Vol. 566, pp. 45-52
Open Access | Times Cited: 18
Dongfu Jin, Jing Wei, Jian Sun
Biochemical and Biophysical Research Communications (2021) Vol. 566, pp. 45-52
Open Access | Times Cited: 18
Showing 18 citing articles:
Review of therapeutic mechanisms and applications based on SARS-CoV-2 neutralizing antibodies
Mingtao Liu, Hui Gan, Zhiman Liang, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 13
Mingtao Liu, Hui Gan, Zhiman Liang, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 13
Therapeutic Role of Neutralizing Antibody for the Treatment against SARS-CoV-2 and Its Emerging Variants: A Clinical and Pre-Clinical Perspective
Manojit Bhattacharya, Srijan Chatterjee, Bidyut Mallik, et al.
Vaccines (2022) Vol. 10, Iss. 10, pp. 1612-1612
Open Access | Times Cited: 17
Manojit Bhattacharya, Srijan Chatterjee, Bidyut Mallik, et al.
Vaccines (2022) Vol. 10, Iss. 10, pp. 1612-1612
Open Access | Times Cited: 17
IgG-like bispecific antibodies with potent and synergistic neutralization against circulating SARS-CoV-2 variants of concern
Matthew Chang, Luke M. Tomasovic, Natalia A. Kuzmina, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 16
Matthew Chang, Luke M. Tomasovic, Natalia A. Kuzmina, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 16
Pre-pandemic SARS-CoV-2-specific IFN-γ and antibody responses were low in Ugandan samples and significantly reduced in HIV-positive specimens
Hellen Nantambi, Jackson Sembera, Violet Ankunda, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
Hellen Nantambi, Jackson Sembera, Violet Ankunda, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
Spotlight on contributory role of host immunogenetic profiling in SARS-CoV-2 infection: Susceptibility, severity, mortality, and vaccine effectiveness
Somayeh Yazdanparast, Mehdi Bakhtiyaridovvombaygi, Fatemeh Mikanik, et al.
Life Sciences (2023) Vol. 328, pp. 121907-121907
Open Access | Times Cited: 7
Somayeh Yazdanparast, Mehdi Bakhtiyaridovvombaygi, Fatemeh Mikanik, et al.
Life Sciences (2023) Vol. 328, pp. 121907-121907
Open Access | Times Cited: 7
SARS‐CoV‐2 neutralising antibody therapies: Recent advances and future challenges
Mingtao Liu, Zhiman Liang, Zhangkai J. Cheng, et al.
Reviews in Medical Virology (2023) Vol. 33, Iss. 5
Closed Access | Times Cited: 4
Mingtao Liu, Zhiman Liang, Zhangkai J. Cheng, et al.
Reviews in Medical Virology (2023) Vol. 33, Iss. 5
Closed Access | Times Cited: 4
Post-vaccination SARS-CoV-2 seroprevalence in children aged 3-11 years and the positivity in unvaccinated children: A retrospective, single-center study
Jing Li, Menglei Ge, Shuzhi Dai, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 6
Jing Li, Menglei Ge, Shuzhi Dai, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 6
Plant virus‐derived nanoparticles decorated with genetically encoded SARS‐CoV‐2 nanobodies display enhanced neutralizing activity
Fernando Merwaiss, Enrique Lozano‐Sanchez, João Zulaica, et al.
Plant Biotechnology Journal (2023) Vol. 22, Iss. 4, pp. 876-891
Open Access | Times Cited: 3
Fernando Merwaiss, Enrique Lozano‐Sanchez, João Zulaica, et al.
Plant Biotechnology Journal (2023) Vol. 22, Iss. 4, pp. 876-891
Open Access | Times Cited: 3
Inhibition of SARS-CoV-2 infection in human airway epithelium with a xeno-nucleic acid aptamer
Niayesh Razi, Weizhong Li, Maxinne A. Ignacio, et al.
Respiratory Research (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Niayesh Razi, Weizhong Li, Maxinne A. Ignacio, et al.
Respiratory Research (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Design of targeted antiviral polypeptides specific to SARS-CoV-2. Challenges and prospects
О. Н. Шилова, Е. С. Шилов, Sergey M. Deyev
Russian Chemical Reviews (2024) Vol. 93, Iss. 6, pp. RCR5128-RCR5128
Closed Access
О. Н. Шилова, Е. С. Шилов, Sergey M. Deyev
Russian Chemical Reviews (2024) Vol. 93, Iss. 6, pp. RCR5128-RCR5128
Closed Access
Concerted deletions eliminate a neutralizing supersite in SARS-CoV-2 BA.2.87.1 spike
Helen M. E. Duyvesteyn, Aiste Dijokaite-Guraliuc, Chang Liu, et al.
Structure (2024) Vol. 32, Iss. 10, pp. 1594-1602.e6
Open Access
Helen M. E. Duyvesteyn, Aiste Dijokaite-Guraliuc, Chang Liu, et al.
Structure (2024) Vol. 32, Iss. 10, pp. 1594-1602.e6
Open Access
Production of Plant Virus-Derived Hybrid Nanoparticles Decorated with Different Nanobodies
Enrique Lozano‐Sanchez, José‐Antonio Daròs, Fernando Merwaiss
ACS Nano (2024)
Open Access
Enrique Lozano‐Sanchez, José‐Antonio Daròs, Fernando Merwaiss
ACS Nano (2024)
Open Access
Interaction between spike protein of SARS-CoV-2 and human virus receptor ACE2 using two-color fluorescence cross-correlation spectroscopy
Ai Fujimoto, Lyu Yidan, Masataka Kinjo, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 3
Ai Fujimoto, Lyu Yidan, Masataka Kinjo, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 3
Interaction between Spike Protein of SARS-CoV-2 and Human Virus Receptor ACE2 Using Two-Color Fluorescence Cross-Correlation Spectroscopy
Ai Fujimoto, Yidan Lyu, Masataka Kinjo, et al.
Applied Sciences (2021) Vol. 11, Iss. 22, pp. 10697-10697
Open Access | Times Cited: 1
Ai Fujimoto, Yidan Lyu, Masataka Kinjo, et al.
Applied Sciences (2021) Vol. 11, Iss. 22, pp. 10697-10697
Open Access | Times Cited: 1
Machine learning for the identification of respiratory viral attachment machinery from sequences data
Kenji C. Walker, Maïa Shwarts, Stepan Demidikin, et al.
PLoS ONE (2023) Vol. 18, Iss. 3, pp. e0281642-e0281642
Open Access
Kenji C. Walker, Maïa Shwarts, Stepan Demidikin, et al.
PLoS ONE (2023) Vol. 18, Iss. 3, pp. e0281642-e0281642
Open Access
The variable conversion of neutralizing anti-SARS-CoV-2 single-chain antibodies to IgG provides insight into RBD epitope accessibility
Matthew Chang, Hanzhong Ke, Laura Losada Miguéns, et al.
Protein Engineering Design and Selection (2023) Vol. 36
Open Access
Matthew Chang, Hanzhong Ke, Laura Losada Miguéns, et al.
Protein Engineering Design and Selection (2023) Vol. 36
Open Access
Inhibition of SARS-CoV-2 Infection in Human Airway Epithelium with a Xeno-Nucleic Acid Aptamer
Niayesh Razi, Weizhong Li, Maxinne A. Ignacio, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Niayesh Razi, Weizhong Li, Maxinne A. Ignacio, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Machine Learning for the Identification of Viral Attachment Machinery from Respiratory Virus Sequences
Stepan Demidkin, Maïa Shwarts, Arijit Chakravarty, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Stepan Demidkin, Maïa Shwarts, Arijit Chakravarty, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access